MFA FINANCIAL, INC.

MFA

CIK 0001055160 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$190M
↑+6.8% +$12Mvs FY2024 (Q4)
Operating Income
$183M
↑+3.0% +$5Mvs FY2024 (Q4)
Net Income
$54M
↑+1479.5% +$51Mvs FY2024 (Q4)
Gross Profit
$190M
↑+6.8% +$12Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Poor
7/100
  • Profitability
    0Insufficient data
  • Liquidity
    0Insufficient data
  • Leverage
    0Insufficient data
  • Efficiency
    0Asset Turnover 0.06x (1.0+ = capital-efficient)
  • Growth
    39Revenue YoY +6.8% (10% = solid, 25%+ = elite)
  • Margin Trend
    0Insufficient data

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project MFA's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

3%

Trailing 3-yr CAGR was -40.1%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$10.24
Total enterprise IV
$1.06B
Diluted shares
0.10B
Terminal PV
$750M (70% of total)
Year-5 FCF
$88M
YearProjected FCFDiscounted PV
+1$79M$71M
+2$81M$67M
+3$83M$63M
+4$86M$59M
+5$88M$55M
Terminal$1.21B$750M

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
investment in PP&E
Dividends paid (TTM)
$148M
cash returned to holders
Stock buybacks (TTM)
$15M
share count reduction
Stock-based comp (TTM)
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$13.05B
everything owned
Total liabilities
$11.22B
everything owed
Stockholders' equity
$1.83B
shareholder claim

Recent performance · 67 quarters

Revenue↑+6.8% +$12M
$190M
Net Income↑+819.3% +$48M
$54M
Free Cash Flow↓-66.2% -$74M
$38M

Drill down